イベルメクチンは広範な哺乳類の細胞に対して細胞生存率を著しく下げる毒性がある According to reports, IVM (1–280 μΜ) can significantly inhibit the cell viability of widely spread non-target mammalian cells (Molinari et al., 2009b, 2013). 本研究では人間の培養細胞に対してイベルメクチンがオートファジーを引き起こし細胞死を促すと判明 In the present study, we found that IVM-mediated proliferation inhibition in HeLa cells were markedly reverted by the addition of 3-MA. The result reflects that IVM can promote cell death by inducing autophagy in HeLa cells. イベルメクチンの細胞毒性メカニズムはAMPK/mTOR由来オートファジーおよびDNA酸化ダメージである可能性がある The mechanism of ivermectin’s cytotoxicity might be the AMPK/mTOR mediated autophagy and oxidative DNA damage. https://www.sciencedirect.com/science/article/pii/S0045653520316428?casa_token=grsoFiHgtasAAAAA:Rw1IbmA3vgPKjiGokdnzHyA5Rn0AeNvf7fruBmCUCJ2D2K0bUWw6wI7sTrQo4A8MTAo0n3-J0hZF0507名無しさん＠お腹いっぱい。2022/07/21(木) 10:45:56.43ID:KHDo8EDu 今朝も元気だ 肝機能数値改善した事は確実 昨晩のイベが全身に行きわたってる安心感 しかし、出先で嫌な奴（Exトモヒコ・ワク信）が目の前でゴホンとするかもしれない
イベルメクチンは広範な哺乳類の細胞に対して細胞生存率を著しく下げる毒性がある According to reports, IVM (1–280 μΜ) can significantly inhibit the cell viability of widely spread non-target mammalian cells (Molinari et al., 2009b, 2013). 本研究では人間の培養細胞に対してイベルメクチンがオートファジーを引き起こし細胞死を促すと判明 In the present study, we found that IVM-mediated proliferation inhibition in HeLa cells were markedly reverted by the addition of 3-MA. The result reflects that IVM can promote cell death by inducing autophagy in HeLa cells. イベルメクチンの細胞毒性メカニズムはAMPK/mTOR由来オートファジーおよびDNA酸化ダメージである可能性がある The mechanism of ivermectin’s cytotoxicity might be the AMPK/mTOR mediated autophagy and oxidative DNA damage. https://www.sciencedirect.com/science/article/pii/S0045653520316428?casa_token=grsoFiHgtasAAAAA:Rw1IbmA3vgPKjiGokdnzHyA5Rn0AeNvf7fruBmCUCJ2D2K0bUWw6wI7sTrQo4A8MTAo0n3-J0hZF0514名無しさん＠お腹いっぱい。2022/07/21(木) 11:33:59.53ID:j0zZdRY+ これが再現された科学的事実なwwww 0515名無しさん＠お腹いっぱい。2022/07/21(木) 11:34:21.11ID:j0zZdRY+ 誰がどんな細胞で試しても必ず発がん性が見つかってしまうwww 0516名無しさん＠お腹いっぱい。2022/07/21(木) 11:35:10.47ID:HvJNEzbB トモヒコもコピペ連投、低学歴連呼じゃ評価が上がらないことにそろそろ気がつけ 歩合給が上がらないのはそういうことだぞ まあ小さい頃から要領悪かったんだろうなあ 0517名無しさん＠お腹いっぱい。2022/07/21(木) 11:48:40.39ID:IE/rvt7d 【2022年2月28日の記事】 巨人は28日、選手、監督、コーチ、スタッフを対象とした新型コロナウイルスワクチンの3回目接種を、東京・大手町の読売新聞東京本社の職域接種会場で開始した。 3月14日までにチームの9割に3回目接種を完了させる予定。 https://www.nikkansports.com/baseball/news/202202280000656.html
Carcinogenicity Chronic (1 year) repeated topical application of SOOLANTRA enhanced simulated solar ultraviolet radiation-induced non-melanoma skin carcinogenesis in albino Skh HR-1 hairless mouse (tumour potency factor in both sexes combined was 1.69; and 1.74 in male mice and 1.51 in female mice; compared with an expected no adverse effect tumour potency factor of 1.00).
Carcinogenicity Chronic (1 year) repeated topical application of SOOLANTRA enhanced simulated solar ultraviolet radiation-induced non-melanoma skin carcinogenesis in albino Skh HR-1 hairless mouse (tumour potency factor in both sexes combined was 1.69; and 1.74 in male mice and 1.51 in female mice; compared with an expected no adverse effect tumour potency factor of 1.00).
In summary, individuals who believed the vaccine is unsafe were especially likely to report lower socioeconomic status, have difficulty understanding scientific information, have higher mistrust in scientific research, and were more likely not to follow scientific recommendations such as masking and vaccination.
In summary, individuals who believed the vaccine is unsafe were especially likely to report lower socioeconomic status, have difficulty understanding scientific information, have higher mistrust in scientific research, and were more likely not to follow scientific recommendations such as masking and vaccination.
Carcinogenicity Chronic (1 year) repeated topical application of SOOLANTRA enhanced simulated solar ultraviolet radiation-induced non-melanoma skin carcinogenesis in albino Skh HR-1 hairless mouse (tumour potency factor in both sexes combined was 1.69; and 1.74 in male mice and 1.51 in female mice; compared with an expected no adverse effect tumour potency factor of 1.00).
Carcinogenicity Chronic (1 year) repeated topical application of SOOLANTRA enhanced simulated solar ultraviolet radiation-induced non-melanoma skin carcinogenesis in albino Skh HR-1 hairless mouse (tumour potency factor in both sexes combined was 1.69; and 1.74 in male mice and 1.51 in female mice; compared with an expected no adverse effect tumour potency factor of 1.00).
